Liu, Lian; Erickson, Nicole Tonya; Ricard, Ingrid et al.
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306) (vol 150, pg 112, 2022)INTERNATIONAL JOURNAL OF CANCER. Bd. 156. H. 1. 2025 S. E1-E1
Hahad, Omar; Schmitt, Volker H.; Baumkoetter, Rieke et al.
Earplug use during sleep and its association with cardiovascular disease - Results from a large sample of the general populationIJC HEART & VASCULATURE. Bd. 57. 2025
Schleicher, Eva Maria; Karbannek, Henrik; Weinmann-Menke, Julia et al.
Effect of albumin treatment duration on response rates and outcomes in patients with cirrhosis and acute kidney injuryJOURNAL OF HEPATOLOGY. Bd. 82. 2025
Schleicher, Eva Maria; Karbannek, Henrik; Weinmann-Menke, Julia et al.
Effect of albumin treatment duration on response rates and outcomes in patients with cirrhosis and acute kidney injuryJOURNAL OF HEPATOLOGY. Bd. 83. H. 3. 2025
Weimer, Johannes; Dirks, Klaus; Ludwig, Michael et al.
Effectiveness of e-learning in internal medicine ultrasound training - Prospective comparison of competence development between students and physiciansINNERE MEDIZIN. Bd. 66. 2025 S. S32-S32
Lim, Ho Yeong; Heo, Jeong; Peguero, Julio A. et al.
Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCCHEPATOLOGY. Bd. 81. H. 1. 2025 S. 32-43
Haidar, Ghady; Thomas, Steven; Loubet, Paul et al.
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA) a randomised, controlled, double-blind, phase 3 trialLANCET INFECTIOUS DISEASES. Bd. 25. H. 7. 2025 S. 813-826
Manfredi, Giulia Francesca; Fulgenzi, Claudia Angela Maria; Celsa, Ciro et al.
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidenceJHEP REPORTS. Bd. 7. H. 8. 2025
Shen, Nan; Weinmann-Menke, Julia; Malvar, Ana et al.
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyRMD OPEN. Bd. 11. H. 3. 2025
Theis, Susanne; Senyigit, Julide; Buechler, Britta et al.
Escalation, maintenance and abstention in oncology a new study design to identify how individual values of patients impact on the assessment of risks and benefits of novel therapeutic concepts in cases of gynaecological tumors and colorectal cancer: a study protocolFRONTIERS IN ONCOLOGY. Bd. 15. 2025